Greenville Health System

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia1 trial
• Chronic myeloid leukaemia1 trial
• Metastatic breast cancer1 trial
• Myelodysplastic syndromes1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Completed3 trials

Lead sponsor

• Pfizer2 trials
• Takeda1 trial

Closed trials

• Completed

  Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)

  NCT03268954· Phase 3· Takeda· Source

• Completed

  Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer

  NCT02007512· Phase 2· Pfizer· Source

• Completed

  Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

  NCT01889238· Phase 2· Pfizer· Source